Your browser doesn't support javascript.
loading
WSP from "Nostoc commune" Vauch. suppresses gastric cancer migration via EGFRVIII signaling.
Chen, Xiaoxia; Bai, Wenqi; Liu, Xiangrong; Zhao, Jiao; Li, Zhiyuan; Li, Jianrong; Su, Liping; Guan, Tao; Sun, Ruifang; Yang, Xihua; Lv, Caixia; Wang, Zhixiang; Hu, Linjie; Li, Zheng; Ma, Jinfeng; Zhang, Huanhu; Lu, Xiaoqing.
Afiliação
  • Chen X; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Bai W; Department of General Surgery Sciences, Shanxi Cancer Hospital, Taiyuan, China.
  • Liu X; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Zhao J; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Li Z; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Li J; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Su L; Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China.
  • Guan T; Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China.
  • Sun R; Cancer Biobank, Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
  • Yang X; Laboratory Animal Center, Shanxi Cancer Institute, Taiyuan, China.
  • Lv C; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Wang Z; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Hu L; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Li Z; Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Ma J; Department of General Surgery Sciences, Shanxi Cancer Hospital, Taiyuan, China.
  • Zhang H; School of Fu Shan, Shanxi University of Chinese Medicine, Jin Zhong, China.
  • Lu X; Department of Breast Surgery, Shanxi Cancer Hospital, Taiyuan, China.
Front Oncol ; 12: 1012863, 2022.
Article em En | MEDLINE | ID: mdl-36568183

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China